ESR2 and cancer: Consistent with the above-reported ERβ anti-proliferative effects [10], it is believed that the chemotherapeutic potential of isoflavones is mainly due to their interactions with ERβ and vary in different cancer types, based upon their specific selectivity for target cells and their concentration, highlighting the complexity of dietary isoflavone functions [147,148,149].